METASTATIC LARGE CELL NEUROENDOCRINE CARCINOMA

Clinical trials for METASTATIC LARGE CELL NEUROENDOCRINE CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new METASTATIC LARGE CELL NEUROENDOCRINE CARCINOMA trials appear

Sign up with your email to follow new studies for METASTATIC LARGE CELL NEUROENDOCRINE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Triple-Drug cocktail shows promise against rare, aggressive cancer

Disease control Ongoing

This study tested a combination of three drugs—cabozantinib, nivolumab, and ipilimumab—in 17 people with advanced, poorly differentiated neuroendocrine cancer that had spread. The goal was to see if the treatment could shrink tumors or stop them from growing. The approach combine…

Matched conditions: METASTATIC LARGE CELL NEUROENDOCRINE CARCINOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated May 17, 2026 08:20 UTC

METASTATIC LARGE CELL NEUROENDOCRINE CARCINOMA

Get alerted when new METASTATIC LARGE CELL NEUROENDOCRINE CARCINOMA trials appear

Triple-Drug cocktail shows promise against rare, aggressive cancer